Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-05 4:43 pm Purchase | 2021-10-26 | 13G | XILIO THERAPEUTICS INC XLO | Atlas Venture Fund XI, L.P. | 144,529 7.600% | 144,529 (New Position) | Filing History |
| 2021-11-05 4:34 pm Purchase | 2021-10-22 | 13G | XILIO THERAPEUTICS INC XLO | RA Capital Management, L.P. | 109,483 5.700% | 109,483 (New Position) | Filing History |
| 2021-11-05 12:54 pm Purchase | 2021-10-26 | 13D | XILIO THERAPEUTICS INC XLO | RiverVest Venture Fund IV L.P. | 102,960 5.400% | 102,960 (New Position) | Filing History |
| 2021-11-04 09:15 am Purchase | 2021-11-04 | 13G | XILIO THERAPEUTICS INC XLO | FMR LLC | 189,834 9.966% | 189,834 (New Position) | Filing History |
| 2021-11-03 4:19 pm Purchase | 2021-10-26 | 13D | XILIO THERAPEUTICS INC XLO | SV7 Impact Medicine Fund LP | 115,259 6.050% | 115,259 (New Position) | Filing History |
| 2021-10-26 7:35 pm Purchase | 2021-10-26 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 163,425 8.580% | 163,425 (New Position) | Filing History |